Mereo BioPharma Announces Update on Distribution Related to Contingent Value Rights Following Recent Oncologie Licensing Agreement for Navicixizumab https://www.biospace.com/article/releases/mereo-biopharma-announces-update-on-distribution-related-to-contingent-value-rights-following-recent-oncologie-licensing-agreement-for-navicixizumab/